Durvalumab vs Nitroglycerin

Durvalumab vs Nitroglycerin: Overview

This comparison examines the pharmacological differences between Durvalumab and Nitroglycerin.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Nitroglycerin: Nitric oxide donor causing venous and arterial vasodilation.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Nitroglycerin — 1-4 minutes.

Chemical Properties

Molecular Formula: Nitroglycerin — C3H5N3O9.

Molecular Weight: Nitroglycerin — 227.0870 g/mol.

Type: Durvalumab — Antibody; Nitroglycerin — Small molecule.